Trials Offered by a Specific Doctor

DEPARTMENT OF RHEUMATOLOGY
Investigator
Elana Bernstein, MD, MSc
Phone
(212) 305-4308
Email
ejb2153@cumc.columbia.edu

Dr. Bernstein's clinical and research interests focus on scleroderma and other fibrosing disorders, as well as on the treatment of pulmonary hypertension and interstitial lung disease in patients with autoimmune diseases. Dr. Bernstein has a special interest in the management of autoimmune diseases during pregnancy. She is an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons and an Assistant Attending at NewYork-Presbyterian Hospital. Dr. Bernstein is the Program Director of the CUMC/NYP Scleroderma Program.

Dr. Bernstein graduated summa cum laude from Amherst College, and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She was the recipient of the American College of Rheumatology Distinguished Fellow Award and the Charles L. Christian Award for Excellence in Musculoskeletal Research while a rheumatology fellow at Hospital for Special Surgery. Dr. Bernstein has received grants from the National Institutes of Health and the Arthritis Foundation to study pulmonary hypertension in scleroderma. Her ongoing research projects focus on pulmonary hypertension in scleroderma and on lung transplant in patients with connective tissue diseases.


Clinical Studies Managed By Dr. Bernstein:
More InfoTitleSponsorIRB Number
Details[CLOSED] Double-blind trial to Test Efficacy of Rituxan (Rituximab) on Systemic Sclerosis-Associated Pulmonary Arterial HypertensionDAIT, NIAID, and NIHAAAO0100
Details[CLOSED] A Study Evaluating Abatacept (Orencia) for Treatment of Systemic SclerosisUniversity of Michigan and Bristol-Myers SquibbAAAO3551
Details[CLOSED] A study for patients with systemic sclerosis using study drug abituzumabEMD Serono Research & Development Institute, Inc.AAAQ6154
Details[CLOSED] Rituximab for Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)NIAID, DAIT, NIHAAAO0100
DetailsGenome Research in African American Scleroderma Patients (GRASP Study)Scleroderma Research FoundationAAAR1503
Details[CLOSED] Abituzumab for patients with SSc-ILD taking mycophenolateMerck EMD SeronoAAAQ6154
DetailsCONQUER Registry to Track Disease Progression in Systemic Sclerosis (Scleroderma)Scleroderma Research FoundationAAAR6143
DetailsAURORA Study: Iloprost for Subjects with Systemic Sclerosis (SSc-Raynaud's Phenomenon)Eicos Sciences, Inc.AAAS5867